The TCR is a 90-kD heterodimeric glycoprotein composed of somatically rearranged a and S chains (1-7). This receptor recognizes a complex consisting of antigenic peptide bound to MHC glycoprotein expressed on APCs and/or target cells (8-10) . The majority of mature T cells expressing TCRa//3 can be separated into two populations, based on their expression of CD4 and CD8 molecules (11, 12) . In the mouse, the subset of T cells expressing the CD8 molecule (Lyt-2 and Lyt-3), but lacking the CD4 (L3T4) molecule, functions as CTL; their interaction with target cells is restricted by class I MHC antigen, whereas the CD4+ CD8 -subset contains helper T lymphocytes (HTL)i whose interaction with APCs and B cells is restricted by class II MHC antigen. It is generally assumed that the process of maturation and selection in the thymus is similar for class I and class II-restricted T cells (13) (14) (15) .
in T cell maturation, either at the double-negative (CD4-8-TCR') stage or at the double-positive (CD4'8'TCR') stage . Secondly, the nonreactivity of mature CD4 -8' Vf6' or Vf8V T cells to Mls might reflect changes in the functional specificity of such T cells imposed by expression of CD8 molecules in the absence of CD4 markers.
To explore a possible role of differential expression of CD4 and CD8 molecules on the functional specificity of T cells, we have established several Va8 .1' T cell hybridomas by fusion of an HTL clone 016 (VS 8.1' CD4'8-, reactive to HY/I-Ab and Mlsa) and a CTL line OH2 (Va8.1' CD4 -8', reactive to HY/H-2D 6 but not to Mls) to two different BW5147 thymoma cell lines (an TCR a-//3-variant and the same variant cell line expressing transfected mouse Lyt-2 molecules). Additional variants of these hybridoma lines lacking CD4 molecules were created by selection with anti-CD4 antibodies and complement. We report here the specificity analyses of these cell lines and show that (a) either the gain of CD8 or the loss of CD4 from the HTL (CD4'8 -, HY/Ab, and Mlsa reactive) line results in the loss of class II-restricted specificity, and (b) the loss of CD8 from the CTL (CD4-8', H-2 Y/Db reactive, and Mls nonreactive) line causes both the loss of class I-restricted specificity and the gain of Mls reactivity by a cell line otherwise not reactive to this molecule . These data provide direct evidence that the CD8 molecule can have a dramatic effect on the specificity of T cells; with the cell lines reported here, it blocks class II MHC-restricted T cell responses, and it blocks responses to Mls by CD4 -T cells.
Materials and Methods
Mice. C57BL/6, B6.C-H-26"''2, B6.C-H-2 6 m", B10 .D2, B10 .BR, DBA/2, and AKR/J mice were purchased from The Jackson Laboratory (Bar Harbor, ME). T Cell Lines and mAbs. Two male antigen-specific T cell clones derived from B6 females, 0112 (CD8', cytolytic) and 016 (CD4' noncyclic), were established and maintained in vitro as described (25) . The TCR a and (3 chain loss variant of AKR-derived thymoma cell line BW5147 was kindly provided by Dr. W. Born (National Jewish Center for Immunology and Respiratory Medicine, Denver, CO). mAbs directed to the V08 TCR (MR5-2) as well as to clonotypic determinants ofOH2 TCR (MR2-6) and 016 TCR (MR5-10) were established as described previously (24) . mAbs directed to Thy-1 (AT 83), L3T4 (GK1.5), and Lyt-2 (3 .155) were kindly provided by Dr. F W. Fitch (University of Chicago, Chicago, IL) (26) .
T Cell Stimulation Assay. For antigen-induced proliferation assays, T cells (2 x 104) were cultured with irradiated (2,000 rad) spleen cells (5 x 105) in flat-bottomed microtiter plates in a final volume of 200 Ad in 5% FCS DMEM. After 72 h of culture and a 6-h pulse with 1 jXi of [3H]thymidine, cultures were harvested onto filters and counted. T cell hybridomas were tested for their ability to produce IL-2 upon stimulation with various spleen cells as described previously (27) . In brief, 105 hybridoma cells were cultured with 5 x 105 stimulator spleen cells (2,000 rad irradiated) in a final volume of 200 Ftl in 5% FCS DMEM in the presence or absence of mAb (1/8, vol/vol) . For the stimulation of the hybridomas with mAbs directed to the TCR, culture plates were coated with mAb overnight and T cells were incubated without stimulator spleen cells . After 24 h of incubation, culture supernatants were harvested and tested for the presence of IL-2 using the IL-2-dependent T cell line CTLL. Results are presented as units of IL-2 per milliter of culture supernatant (28) .
Lyt-2 Gene Transfection and the Establishment of T-T Hybridomas . A plasmid containing the Lyt-2 gene and bacterial gpt gene (pCA208) (29) was kindly provided by Dr. B. Malissen (INSERM-CNRS de Marseille-Luminy, France) . The plasmid (20 pg) and 5 x 106 TCRa-/S-BW5147 cells were suspended in 0.5 ml PBS (pH 7.4) and electroporated using a BTX 100 power supply (BTX, San Diego, CA) . The cells were cultured in complete culture medium in 96-well microtiter plates. After 48 h of incubation, cells were selected for the expression ofthe transfected gene using mycophenolic acid (2 Rg/ml), xanthine (250 p,g/ml), and hypoxanthine (15 leg/ml) . Growing cells were expanded, selected for the expression of Lyt-2 gene expression and cloned . T-T cell hybridomas were established as described previously (30) . For the selection of the BW Lyt-2 x T cell clone hybridomas, since the transfected gpt gene confers on the thymoma cell line resistance to HAT selection, hybridomas cultured in HAT medium were selected for the expression of both Thy-1 .1 (BW thymoma origin) and Thy-1 .2 (T cell clone origin) alloantigens by extensive panning, cloned, and tested for the expression of surface TCR and Lyt-2 alloantigen . CD4 -variants of hybridomas were established by two cycles of anti-mouse CD4 mAb plus complement treatment and cloning .
Flow Cytometry Analysis. The analysis was performed as described previously (25) . In brief, cells (10 6) were incubated with 100 pl of hybridoma culture supernatant for 30 min on ice followed by adding FITC-conjugated second reagent for an additional 30-min incubation. Stained samples were analyzed using FACScan analyzer. Control samples were prepared in the same manner but without the first mAb . (Table I ). Both clones exhibited strong proliferative responses upon stimulation with B6 (H-2b) male spleen cells but not with B6 female spleen cells ( Table 1 ). The restriction specificity of both clones was more precisely defined by the finding that 016 T cells failed to respond to bm12 (I-Ab mutant) male stimulator cells, and the OH2 T cells did not respond to bm14 (Db mutant) male spleen cells (Table I) .
Results

Mls
When 016 and OH2 cells were stimulated with spleen cells from various strains of mice, it was found that 016, but not OH2 cells, could respond to stimulator cells from Mlsa-positive strains, even those with different H-2 haplotypes, but not to stimulators from Mlsa-negative strains (Table I ). The Mlsa specificity of the 016 T cell clone was confirmed by using various stimulator cells expressing different MHC and Mls antigens (data not shown).
Antigen-specific proliferative responses of OH2 and 016 T cells were inhibited by either mAb MR5-2 (antiV/3 8) or the anticlonotypic mAbs, MR2-6 (specific for OH2 TCR) and MR5-10 (specific for 016 TCR) ( Table I) . These data clearly demonstrate that (a) the CD4'8-clone 016 is reactive to H-Y + Ab and Mls, while the CD4-8' clone OH2 is reactive only to HY + Db , and (b) TCR molecules identified by antiV08 and anticlonotypic mAbs are involved in these responses to Mls and HY.
Antigen Specificity of T-THybridomas. To better understand the basis for the failure of OH2 T cells to respond to Mlsa antigen, a panel of T cell hybridomas was generated with OH2 and 016 T cells. The parent cell line used for the fusion was a variant of the BW5147 cell line (ot-(3-BW) that lacks expression of both endogenous cr and a chains ofthe TCR due to irradiation-induced deletions ofthese genes. Both OH2 and 016 cell lines were fused with the a-o-BW cell line and selected in HAT medium. Growing hybridomas were cloned under limiting dilution conditions and selected for expression of either OH2 or 016 derived TCR . 
When these hybridomas were tested for antigen specificity by measuring IL-2 production upon stimulation with spleen cells, hybridoma KR3, established by fusing 016 T cells with the a-fl-BW cell line, was found to exhibit the same regimen specificity as the original 016 T cell clone, namely to H-Y + I-Ab and Mls (Table  II A ). In contrast, the hybridoma KV24, established by fusing the CTL clone OH2 with BW, was incapable of producing IL-2 upon stimulation with B6 male spleen cells, but surprisingly it showed response to Mls (Table II A) . This was confirmed in another experiment where KV24 failed to show alloreactivity to B10.BR (H-2k, Mlsb), but showed good responses to AKR/J, RF/J, and CBA/J strains expressing Mlsa antigen and the same H-2k haplotype (result not shown).
To determine whether this Mls-specific response of the KV24 hybridoma was mediated by the TCR of the original OH2 CTL clone, hybridomas were stimulated by AKR spleen cells in the presence or absence ofthe antiTCR mAbs (MR5-2, MR2-6 and MR5-10). As shown in the Table II B, the Mlsa-specific responses of both KV24 and KR3 were inhibited by mAb MR5-2 specific for the V#8 TCR. The finding that the anticlonotypic mAb MR2-6 that is directed to the OH2 TCR was also capable of inhibiting the Mlsa-specific response of the KV24 hybridoma, but not KR3, indicated that the TCR of the CTL clone OH2 was responsible for the Mlsa specificity of the KV24 hybridoma.
The phenotype of hybridomas KV24 and KR3 were analyzed by surface immunofluorescent staining (Table II C) . Hybridoma KR3 was found to express the CD4 molecule ; however, KV24, derived from the CD8+ OH2 cell line, was found to be negative for the expression of the CD8 molecule. A requirement for CD8 mol- The antigen-specific IL-2 production by the T cell hybridomas and inhibition of antigen-specific T cell response with mAbs was measured as described in Materials and Methods . Surface phenotype of the hybridomas was analyzed by immunofluorescence staining using the mAbs described in Materials and Methods . ' Irradiated spleen cells . I IL-2 units per milliliter of culture supernatant . The minimum detectable unit in our assay was 1 U/ml . ecules in class I-restricted antigen recognition by CTL has been well documented, thus the failure of KV24 to respond to B6 male spleen cells may be due to the lack of expression of CD8.
Establishment of V,88.1* Hybridomas Expressing Different CD4JCD8 Phenotypes. Given the special circumstances of the KV24 hybridoma, lacking CD8 and the concomitant appearance of Mls reactivity, we decided to assess the role of CD8 molecule on the functional antigen specificity of the hybridomas. First the CD8 gene was introduced into an a-ß-BW cell line by gene transfection . CD8+ BW5147 cells (BW CD8) were then used to establish hybridomas with the OH2 CTL (NA3 hybridomas) and 016 HTL (NB hybridoma) . The NA3 hybridoma (OH2 CTL x BW CD8) cells were cloned and shown to express both the CD8 molecule and TCR derived from OH2 ( Fig. 1 A) . The NB hybridoma (016 x BW CD8) NB were tested in a similar manner and shown to be CD8+ and TCR+ (Fig. I B) .
effect of CD8 expression in the absence of the CD4 molecule on TCR HTL x BW hybridomas, the KR3 (CD8-, CD4+, TCR+) and NB hybridomas were treated with anti-CD4 mAb and complement . Clones KR3N (CD4-, CD8 -, TCR+) and NZB7.3 (CD8+, CD4-, TCR+) were selected (Fig. 1 B) . The amount of TCR expressed on these selected hybridomas was found to be significantly less .
The functional antigen specificity ofthese various manipulated V08.1 hybridomas expressing the HTL 016 and CTL 0112 TCR was determined in IL-2 assays by stimulation with splenic cells from several different strains (Table III) . The data can be summarized as follows: First, for hybridomas derived from 0112 (CD4-8 + , HY/Db reactive, and Mls nonreactive), the loss of CD8 (KV24, CD4-8 -) is accompanied by the loss of class I-restricted reactivity and the gain of Mls reactivity. Thus, as expected, loss of CD8 causes diminished responses to class I-restricted antigen, but it also causes the appearance of a new reactivity to Mls. The introduction of CD8 molecule into hybridoma (NA3) restored the class I-restricted HY response, but resulted in the loss of Mls reactivity.
Second, for hybridomas derived from the dual reactive 016 clone (CD4+ 8-, HY/I-Ab and Mls reactive), either the loss of CD4 (KR3N, CD4-8 -) , or the gain of CD8 (NB9 .1, CD4+8+) causes nonreactivity to a class II MHC-restricted antigen. In addition, for cells bearing this TCR, the presence of CD8 in the absence of CD4 blocks Mls responses. Hybridomas were stimulated with either irradiated spleen cells or anti-TCR mAb (MR2-6 and MR5-10 for OH2 and 016 hybridomas, respectively) fixed onto the culture plates and amount of IL-2 produced was measured as described in the Materials and Methods . IL-2 U/ml of culture supernatant .
Discussion The experiments reported here explore the effects on the functional specificity of two different Vf8.1 C57BL/6 T cell clones caused by manipulating their expression of CD4 and CD8 molecules. One of these V08.1 clones, a HTL (016), is CD4'8-and is reactive to H-Y restricted by MHC class II molecules (I-Ab) and is also Mlsa reactive ; the second V08.1 clone, a CTL line (OH2), is CD4-8' and reacts only to HY restricted by MHC class I (Db). These clones were fused to the TCRa-/a_ variant of BW5147 that extinguishes CD8 expression, or to a reengineered TCRa-//3-, CD8' variant of BW5147, in which case resulting hybridomas continued to express CD8. Loss of CD4 expression was caused by selection in culture in the presence of anti-CD4 antibodies and complement . At each step in the manipulation of the CD4/CD8 phenotype, the resulting hybridomas were assessed for reactivity to HY/I-Ab, HY/Db, Mls, and to triggering by immobilized mAbs specific for V08 and clonotypic markers of the TCR ci,o chains .
The results presented in Table III demonstrate the effect of altering CD4/CD8 phenotypes on the functional specificity of these cells. First, the results show that either the loss of CD4 (KR3N, CD4-8-) or the gain of CD8 (NB9.1, CD4'8') by HTL CD4'8 -, HY/I-Ab, Mls reactive cells with the 016 TCR is accompanied by the loss of reactivity to HY/I-Ab while Mls responses are retained . Subsequent loss of CD4 from NB9.1 (CD4'8') in the NB7.3 line (CD4 -8') loses reactivity to both antigens . From these findings we conclude that (a) the presence of CD4 is required for class II-restricted reactivity, but not for Mls responses; (b) responses to class II MHC-restricted antigens, but not to Mls, are inhibited in CD4' cells by the presence of CD8 molecules; and (c) the presence of CD8 in a CD4-cell extinguishes responses both to class II-restricted antigens and Mls.
Second, with V08.1 cells of the CD4-8' phenotype, bearing the OH2 CTL receptor, reactive to HY/Db only, the loss of CD8 is accompanied, as expected, by the loss ofclass I MHC-restricted specificity, but what may not have been expected is that loss of CD8 in this otherwise Mls nonreactive cell line also endowed it with a new reactivity to Mls. From this finding we conclude, as have others, that class I- restricted responses rely heavily on CD8, and that CD8 blocks Mls responses in CD4-T cells, as discussed above for 016 TCR.
The results of the present analyses correlating specificity of V08.1+ T cells with their CD4/CD8 phenotypes involve only a limited number of different Va8 .1' TCR. Consequently, it is not yet certain whether they apply to all T cells using V08.1 TCR. Nevertheless, we have recently examined three additional CTL CD4 -8' clones and hybridomas derived from them; all expressed V06 or V08.1, and all were reactive to class I-restricted antigens but not to Mls. By contrast, of several HTL CD4+8-, class II MHC-restricted clones expressing V/36 or Va8.1, all were reactive to Mls (Kanagawa, 0., unpublished data).
In this report, we have found that the TCR density on the hybridomas expressing different CD4, CD8 phenotypes differs significantly and this TCR density difference might affect the antigen reactivity of the hybridomas . However, CD4-8-hybridomas expressing varying degree of OH2 TCR exhibited similar Mls reactivity (Kanagawa, 0., unpublished data), suggesting the minor effect of TCR density on Mls reactivity of 0142 TCR.
If V08 Similar conclusions were reached by von Boehmer and his colleagues using transgenic mice expressing TCR a and a chains (32) . The majority of T cells in these mice were potentially reactive to HY/Db. Three important observations were made in comparing male and female H-26 mice expressing these transgenis: males showed (a) a marked reduction (ti90%) in numbers of CD4+8+ thymocytes, (b) reduced numbers of CD4'8-cells, and (c) the presence of transgene-expressing T cells with very low levels of CD8 expression . The common feature of both these examples is that CD4-8' V06 T cells are deleted in Mls+ strains, and CD4+8-VR8+ T cells are deleted in the male transgenic mice, but neither cell population shows any reactivity to its respective antigen.
The point to be emphasized here is that the functional specificity ofa given TCR a/(3+ cell, consequently its selectivity in the thymus, depends on its CD4/CD8 phenotype, and its reactivity to a particular ligand can be changed by altering expression of CD4 or CD8 molecules without directly changing its receptor molecules. Several examples of this are presented in this paper: (a) starting from a CD4+8-clone, loss of CD4 or the gain of CD8 extinguishes class II MHC reactivity, but Mls responses remain intact ; (b) subsequent loss of CD4 from a CD4+8+ clone causes loss of Mls reactivity ; and (c) loss of CD8 from a CD4-8' clone blocks class I reactivity but it also causes the appearance of Mls reactivity.
The involvement of CD8 molecules in class I-restricted recognition has been demon-strated in the past by experiments involving blocking with anti-CD8 antibodies (33, 34) , transfection with CD8 genes (29, 35) , and direct cell adhesion studies (36) . The current study shows yet another effect o£ the presence of CD8 molecules on T cell specificity: in double-positive CD4'8' T cells they inhibit class II-restricted responses while allowing recognition of MIS, and in CD4-8' T cells, they block MIS recognition. Just how this occurs is not clear, but the following scenario seems worth considering. At least with the pair of Vß8.1 TCR used in this study, the requirement for CD4 in TCR-class II interactions might be for avidity sufficient to cause triggering by esence of CD8 molecules interferes with this interaction, perhaps by competing with CD4 for a common interaction site . The avidity of TCR MIS interactions seems to override CD8 inhibition in the presence of CD4 molecules, but not in their absence.
We do not know whether the double specificity of a single TCR is true for every CTL TCR using the class II or MIS reactive Vß chains (Vß 3, 6, 8.1, and 17a) as part of the surface receptor for antigen. Manipulation of CD4/8 phenotypes of T cell clones and hybridomas by methods described in this report and further analysis of antigen specificity of these manipulated hybridomas is now underway to resolve these puzzling and fundamenal issues of T cell recognition. Summary T cell hybridomas were established by fusing a CD8' Vß8.1' CTL clone and a CD4' Vß8.1' helper T lymphocyte (HTL) clone to the thymoma cell line BW5147. In contrast to the HTL x BW hybridomas, which retain the same antigen specificity as the original T cell clone, the CTL x BW hybridomas lost the class I MHC-restricted antigen response but acquired a new specificity to MIsa antigen. MIsa reactivity of CTL x BW hybridomas was shown to be mediated by the CTL TCR as assayed by inhibition using an anticlonotypic antibody to the CTL clone. Since hybridomas established with BW5147 lose CD8 expression, we have introduced the CD8 molecule into CTL x BW5147 hybridomas by gene transfection . The CD8' Vß8.1' hybridoma was no longer capable of reacting to Mlsa antigen but exhibited the same ificity as the parental CTL clone. Furthermore, the presence of the transfected CD8 molecule in the HTL x BW hybridomas was found to be inhibitory to class II MHC-restricted antigen reactivity. These results demonstrate that, be sides its role in increasing the overall avidity ofT cell-class I MHC/antigen interacinhibits T cell-class II MHC gene product/antigen interaction. This negative effect ofthe CD8 molecule on a class II MHC-restricted response may account for the failure of CD8' T cells using either Vß8.1 or Vß6, which impart reactivity to the MIsa antigen on CD4' T cells, to respond to the MIsa antigen.
